Generated by AI
Summary of Jul 16's posts. Generated by AI.
Summary of Mar 4's posts. Generated by AI.
Summary of May 15's posts. Generated by AI.
Investors talking about CDIO also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.
Cardio Diagnostics Holdings, Inc. is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular disease. The company’s current offerings include blood-based diagnostics for coronary heart disease risk assessment and early detection, supported by AI-driven analysis of genetic and epigenetic biomarkers. Cardio Diagnostics also provides tools and platforms that help clinicians interpret cardiovascular risk and support research and development use in biopharmaceutical and medical settings. Its products are designed to improve the assessment, detection, and management of cardiovascular conditions such as coronary heart disease and related comorbidities through more precise clinical insights. Based in Chicago, Illinois, Cardio Diagnostics Holdings serves the growing market for advanced cardiovascular diagnostics and precision medicine.
Website311 West Superior Street
Chicago, IL, 60654
United States
The latest articles about CDIO.
CHICAGO, August 26, 2026--Cardio Diagnostics has released a new edition of the company’s rural health report: The State of Rural Hospitals and Cardiovascular Care.